Mortality and morbidity of curative and palliative anticancer treatments during the COVID‑19 pandemic: A multicenter population‑based retrospective study

Author:

Tashkandi Emad1ORCID,Al‑Abdulwahab Amal2,Basulaiman Bassam3,Alsharm Abdullah3,Al‑Hajeili Marwan4,Alshadadi Faisal4,Halawani Lamis4,Al‑Mansour Mubarak5,Alquzi Bushra6,Barnawi Samar6,Alghamdi Mohammed7,Abdelaziz Nashwa7,Azher Ruqayya8

Affiliation:

1. Department of Medicine, College of Medicine, Umm Al‑Qura University, Makkah 21421, Saudi Arabia

2. Department of Medical Oncology, Oncology Center, King Abdullah Medical City, Makkah 24246, Saudi Arabia

3. Department of Medical Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh 11564, Saudi Arabia

4. Department of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia

5. Department of Medical Oncology, College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah 21423, Saudi Arabia

6. Department of Medical Oncology, Princess Noorah Oncology Center, King Abdulaziz Medical City, Ministry of National Guard Health Affairs‑Western Region, Jeddah 21423, Saudi Arabia

7. Department of Medical Oncology, College of Medicine, King Saud University, Riyadh 11362, Saudi Arabia

8. Community Medicine Department, Umm Al‑Qura University, Makkah 21421, Saudi Arabia

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3